Highest-materiality recent filing
Globe Life director David A. Rodriguez retires from board effective Aug 4, 2026
David A. Rodriguez retired from Globe Life Inc. Board of Directors on August 4, 2026, effective immediately.
Globe Life Q2 EPS $3.65 beats $3.05 YoY; raises FY guidance to $15.55-$15.95
Net income per diluted share $3.65 vs $3.05 YoY (+20%); net operating income per share $3.61 vs $3.27 (+10%).
Globe Life amends credit facilities: $1B revolver extended to 2031, term loan raised to $450M
Third Amended and Restated Credit Agreement: $1B revolving credit facility, maturity extended to June 26, 2031.
Two directors retire; shareholders approve say-on-pay and 2026 incentive plan
Directors Linda L. Addison and Marilyn A. Alexander retired from board at April 30, 2026 annual meeting.
Globe Life Q1 EPS $3.39 vs $3.01 YoY; raises FY2026 guidance to $15.40-$15.90
Net operating income per share $3.43, up 12% YoY; net income per share $3.39, up 13% YoY.
Globe Life expands board to 14, appoints Derek Kan and Sandra Phillips as independent directors
Board expanded from 12 to 14 directors; Derek T. Kan and Sandra L. Phillips appointed effective Feb 25, 2026.
Q4 net income $3.29/share vs $3.01 YoY; net operating income $3.39 vs $3.14, up 8%.
Globe Life amends SERP; revises early retirement factors and adds change-of-control vesting
New early retirement reduction factors: 50% at age 55, stepping up to 100% at age 65.
Globe Life Q3 net income $4.73/share, up 38% YoY; FY2025 guidance $14.40-$14.60
Net income per diluted share $4.73 vs $3.44 YoY; net operating income $4.81 vs $3.49 YoY.
Globe Life announces SEC investigation concluded with no enforcement action; DOJ also closes probe
SEC staff notified Globe Life they have concluded investigation and do not intend to recommend enforcement action.
Globe Life Q2 net income $3.05/sh (up 8% YoY); operating EPS $3.27 (up 10%)
Net income per diluted share $3.05 (+8% YoY); operating EPS $3.27 (+10%).
Globe Life closes $500M P-Caps issuance for contingent liquidity facility due 2055
Issued 500,000 P-Caps at $1,000 each for $500M total; trust invested proceeds in U.S. Treasury strips.
Globe Life Q1 net op income $3.07/sh, beats expectations; net income $3.01/sh, +13% YoY
Net operating income $3.07 per diluted share vs $2.78 YoY (+10%), above management expectations.
Globe Life director Steven P. Johnson retires; all 12 directors elected at annual meeting
Steven P. Johnson retired from the Board effective April 24, 2025, at the Annual Meeting.
Globe Life expands board to 13, appoints two new independent directors
Board expanded from 11 to 13 members; Matthew J. Adams and Philip M. Jacobs appointed.
Globe Life Q4 net operating income $3.14 vs $2.80 YoY; guides FY2025 $13.45-$14.05
Q4 net operating income $3.14/diluted share (up 12% YoY); net income $3.01/diluted share.
Threat actor obtained PII of ~5,000 individuals (names, SSNs, health data, etc.); no financial data.
Globe Life adopts executive severance plan; Co-CEOs get 2x pay multiple
Plan covers Co-CEOs and other Named Executive Officers; severance multiples of 2x (Co-CEOs) or 1.5x (others) of base salary plus target bonus.
Globe Life announces blackout for Savings Plan due to record keeper change from Empower to Fidelity
Blackout runs from 3:00 pm CT Dec 6, 2024 through the week of Dec 29, 2024.
Globe Life Q3 NOI $3.49, up 29% YoY; guides FY24 $12.20-12.40, FY25 $13.20-13.90
Q3 net income $3.44/diluted share vs. $2.68 YoY; net operating income $3.49 vs. $2.71 YoY (19% increase).
Globe Life discloses extortion attempt involving customer data of ~5,000 individuals
Unknown threat actor seeks extortion; company activated response plan with external experts and federal law enforcement.
EEOC finds reasonable cause for discrimination claims against Globe Life; company disputes status
EEOC found reasonable cause that Globe Life/AIL discriminated on sex (6 complainants) and race (1 complainant), plus pattern-or-practice against female workers of SGA Simon Arias.
Globe Life issues $450M of 5.850% Senior Notes due 2034
Issued $450M aggregate principal of 5.850% Senior Notes due Sept 15, 2034 at 99.799% of par.
Globe Life upsizes delayed-draw term loan to $250M, extends maturity to 2027
Principal amount increased from $170M to $250M under First Amendment.
Net income $258.4M ($2.83 diluted) vs $215.3M ($2.24) in Q2 2023; net operating income $271.2M ($2.97) vs $251.5M ($2.61).
Globe Life audit committee finds no merit to short-seller allegations after independent review
Audit Committee completed independent investigation of allegations by Fuzzy Panda Research and Viceroy Research.
On June 13, 2024, following a state regulator inquiry, Globe Life found likely unauthorized access to consumer/policyholder info via a web portal's access permissions.
Globe Life receives SEC informal inquiry regarding short seller allegations
SEC Fort Worth Regional Office made preliminary informal inquiry related to recent short seller reports alleging misconduct.
Globe Life board member Jane Buchan retires; all directors elected at annual meeting
Jane Buchan retired from the Board of Directors at the Annual Meeting on April 25, 2024.
Globe Life Q1 net income $2.67/sh, up 14% YoY; guides FY NOI $11.50-$12.00
Net income $254.2M ($2.67/diluted share) vs $223.6M ($2.28) YoY; net operating income $264.1M ($2.78) vs $248.0M ($2.53).
Globe Life upsizes revolving credit facility to $1.0B, extends maturity to 2029
Revolving credit facility increased from $750M to $1.0B; ability to request further increase up to $1.25B.
Former agent's claims against AIL and Arias dismissed with prejudice; no payment or relief obtained.
Globe Life Q4 net income $2.88/share, up 17%; FY2024 operating EPS guide $11.30-$11.80
Net income $274.8M ($2.88/diluted share) vs $242.3M ($2.46) YoY; net operating income $267.4M ($2.80) vs $251.3M ($2.55).
Globe Life adopts new Management Incentive Plan effective Jan 1, 2024
Board adopted new Management Incentive Plan (MIP) effective Jan 1, 2024.
Globe Life Q3 net income $2.68/diluted, up 38% YoY; net operating income $2.71
Net income per diluted share $2.68 vs $1.94 YoY; net operating income $2.71 vs $2.19.
Globe Life board reaffirms stock repurchase program with no expiration or share limit
Board reaffirmed stock repurchase program on August 10, 2023.
Globe Life amends bylaws for Universal Proxy Rules and DGCL updates
Nominations must represent intent to solicit proxies from 67%+ voting power per Universal Proxy Rules.
Globe Life Q2 operating income $2.61/sh (+3% YoY); guides FY23 $10.37-$10.57/sh
Net income $2.24/sh ($215.3M), down from $2.26/sh; net operating income $2.61/sh ($251.5M), up 3% from $2.54/sh.
Globe Life Q1 net income $2.28/diluted share vs $2.37 YoY; operating income $2.53, up 4%
Net income $2.28/diluted share vs $2.37 YoY; net operating income $2.53 vs $2.43 (+4%).
Globe Life shareholders approve officer exculpation, say-on-pay, and director slate
Charter amended to exculpate officers for certain fiduciary duty breaches, matching director protections.
Globe Life enters $170M delayed draw term loan agreement with BofA-led syndicate
Unsecured delayed draw term loan up to $170M; minimum draw $150M, available until May 15, 2023.
Board expanded to 14; Alice S. Cho and David A. Rodriguez appointed as independent directors effective Feb 22, 2023.
Co-Chairmen Coleman and Hutchison to retire at annual meeting; Co-CEOs to succeed
Gary L. Coleman and Larry M. Hutchison will retire as Directors and Co-Chairmen at the April 27, 2023 annual meeting.
Globe Life Q4 net income $2.14 per share, up 22% YoY; FY 2023 guidance $10.20-$10.50
Net income per share $2.14 (Q4 2022) vs $1.76 a year ago; net operating income $2.24 vs $1.70.
Globe Life Q3 net operating income $2.15/sh, +21% YoY; issues 2023 guidance
Net operating income per diluted share $2.15 vs $1.78 in Q3 2021, up 21%.
Coleman and Hutchison step down as co-CEOs; Darden and Svoboda to succeed Jan 1, 2023
Co-CEOs Coleman and Hutchison retire as CEOs effective Dec 31, 2022, remain co-chairmen.
Globe Life Q2 operating EPS $2.07, up 12% YoY; guides FY $7.90-$8.30; repurchases 1.4M shares
Net operating EPS $2.07 vs $1.85, +12% YoY; net income EPS $1.79 vs $1.92.
Globe Life issues $400M of 4.800% Senior Notes due 2032, uses proceeds to repay $300M notes due 2022
$400M aggregate principal of 4.800% Senior Notes due 2032 issued at 99.672% of par.
Globe Life director Charles E. Adair retires; all 12 board nominees elected at annual meeting
Charles E. Adair retired from the board effective April 28, 2022, immediately prior to the annual meeting.
Globe Life Q1 net op income $1.70/share, up 11% YoY; cuts FY2022 guidance on COVID claims
Net operating income $1.70/diluted share, up 11% YoY; net income $1.64/diluted share, down 4% YoY.
On August 4, 2026, David A. Rodriguez retired from the Board of Directors of Globe Life Inc. (the “Company”), effective immediately, for personal reasons.
Linda L. Addison and Marilyn A. Alexander retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 30, 2026.
Linda L. Addison and Marilyn A. Alexander retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 30, 2026.
Steven P. Johnson retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 24, 2025.
appointed Matthew J. Adams and Philip M. Jacobs to fill the newly-created directorships.
appointed Matthew J. Adams and Philip M. Jacobs to fill the newly-created directorships.
Jane Buchan retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 25, 2024.
The Board appointed Alice S. Cho and David A. Rodriguez to fill the newly-created directorships.
The Board appointed Alice S. Cho and David A. Rodriguez to fill the newly-created directorships.
Darren M. Rebelez notified the Board of his intention to retire as a director of the Company at the Annual Meeting of Shareholders on April 27, 2023, and not stand for re-election.
It is the present intention of the Board for Globe Life’s Co-Chief Executive Officers, J. Matthew Darden and Frank M. Svoboda, to succeed Messrs. Coleman and Hutchison as Co-Chairmen of the Board upon their retirement and contingent upon Messrs. Darden and Svoboda’s election to the Board at the Annual Meeting.
It is the present intention of the Board for Globe Life’s Co-Chief Executive Officers, J. Matthew Darden and Frank M. Svoboda, to succeed Messrs. Coleman and Hutchison as Co-Chairmen of the Board upon their retirement and contingent upon Messrs. Darden and Svoboda’s election to the Board at the Annual Meeting.
Max materiality 0.85 · Median 0.60 · Most common event earnings